Literature DB >> 27407884

Newer Diagnostic Methods in Oncology.

L Goyal1, S Hingmire1, Purvish M Parikh2.   

Abstract

Keywords:  Flowcytometry; Immunohistochemistry; MRS; Oncology diagnosis; PCR

Year:  2011        PMID： 27407884      PMCID： PMC4921993          DOI： 10.1016/S0377-1237(06)80062-6

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


× No keyword cloud information.
  31 in total

1.  Expression of adhesion molecules in B-cell chronic lymphocytic leukaemia: an analysis in lymphoid compartments--peripheral blood, bone marrow and lymph node.

Authors:  J J Nadkarni; S M Perambakam; V B Rathore; K M Amin; P M Parikh; K N Naresh; S H Advani
Journal:  Cancer Biother Radiopharm       Date:  1998-08       Impact factor: 3.099

2.  Pathology of Barrett's esophagus by proton magnetic resonance spectroscopy and a statistical classification strategy.

Authors:  Sinead T Doran; Greg L Falk; Ray L Somorjai; Cynthia L Lean; Uwe Himmelreich; Jeanette Philips; Peter Russell; Brion Dolenko; Alexander E Nikulin; Carolyn E Mountford
Journal:  Am J Surg       Date:  2003-03       Impact factor: 2.565

3.  Differentiation of chronic focal pancreatitis from pancreatic carcinoma by in vivo proton magnetic resonance spectroscopy.

Authors:  Soon Gu Cho; Don Haeng Lee; Keon Young Lee; Hoon Ji; Kyung Hee Lee; Pablo R Ros; Chang Hae Suh
Journal:  J Comput Assist Tomogr       Date:  2005 Mar-Apr       Impact factor: 1.826

Review 4.  Magnetic resonance imaging of the breast.

Authors:  C P Goscin; C G Berman; R A Clark
Journal:  Cancer Control       Date:  2001 Sep-Oct       Impact factor: 3.302

5.  Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns.

Authors:  S Gruvberger; M Ringnér; Y Chen; S Panavally; L H Saal; M Fernö; C Peterson; P S Meltzer
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

6.  Virtual bronchoscopy for evaluation of malignant tumors of the thorax.

Authors:  Steven E Finkelstein; Ronald M Summers; Dao M Nguyen; John H Stewart; Jean A Tretler; David S Schrump
Journal:  J Thorac Cardiovasc Surg       Date:  2002-05       Impact factor: 5.209

7.  The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.

Authors:  Hiroyuki Kato; Tatsuya Miyazaki; Masanobu Nakajima; Junko Takita; Hitoshi Kimura; Ahmad Faried; Makoto Sohda; Yasuyuki Fukai; Norihiro Masuda; Minoru Fukuchi; Ryokuhei Manda; Hitoshi Ojima; Katsuhiko Tsukada; Hiroyuki Kuwano; Noboru Oriuchi; Keigo Endo
Journal:  Cancer       Date:  2005-01-01       Impact factor: 6.860

8.  Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer.

Authors:  Fred R Hirsch; Marileila Varella-Garcia; Paul A Bunn; Wilbur A Franklin; Rafal Dziadziuszko; Nick Thatcher; Alex Chang; Purvish Parikh; José Rodrigues Pereira; Tudor Ciuleanu; Joachim von Pawel; Claire Watkins; Angela Flannery; Gillian Ellison; Emma Donald; Lucy Knight; Dinah Parums; Nicholas Botwood; Brian Holloway
Journal:  J Clin Oncol       Date:  2006-11-01       Impact factor: 44.544

Review 9.  Improved imaging and the clinician: the role of positron emission tomography in the management of colorectal cancer.

Authors:  Joel Randolph Hecht
Journal:  Mol Imaging Biol       Date:  2004 Jul-Aug       Impact factor: 3.488

10.  (1)H magnetic resonance spectroscopy of preinvasive and invasive cervical cancer: in vivo-ex vivo profiles and effect of tumor load.

Authors:  Marrita M Mahon; I Jane Cox; Roberto Dina; W Patrick Soutter; G Angus McIndoe; Andreanna D Williams; Nandita M deSouza
Journal:  J Magn Reson Imaging       Date:  2004-03       Impact factor: 4.813
View more
  1 in total

Review 1.  Molecular Docking as a Therapeutic Approach for Targeting Cancer Stem Cell Metabolic Processes.

Authors:  Babak Arjmand; Shayesteh Kokabi Hamidpour; Sepideh Alavi-Moghadam; Hanieh Yavari; Ainaz Shahbazbadr; Mostafa Rezaei Tavirani; Kambiz Gilany; Bagher Larijani
Journal:  Front Pharmacol       Date:  2022-02-21       Impact factor: 5.988
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.